O. Laure, P. Saskya, P. Jérôme, P. Isabelle, S. Antoine et al., Tandeau de Marsac Thibault. Farhat Mighri kindly supported the study team in the remote area of El Mnara Isoenzyme typing was performed by

A. Magill, Cutaneous leishmaniasis in the returning traveler, Infectious Disease Clinics of North America, vol.19, issue.1, pp.241-266, 2005.
DOI : 10.1016/j.idc.2004.11.005

J. Blum, P. Desjeux, E. Schwartz, B. Beck, and C. Hatz, Treatment of cutaneous leishmaniasis among travellers, Journal of Antimicrobial Chemotherapy, vol.53, issue.2, pp.158-166, 2004.
DOI : 10.1093/jac/dkh058

P. Buffet, E. Caumes, and M. Gentilini, Treatment of localized cutaneous leishmaniasis], Ann Dermatol Venereol, vol.121, pp.503-511, 1994.

S. Belazzoug and R. Neal, Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.80, issue.4, pp.670-671, 1986.
DOI : 10.1016/0035-9203(86)90176-8

J. Berman, Current treatment approaches to leishmaniasis, Current Opinion in Infectious Diseases, vol.16, issue.5, pp.397-401, 2003.
DOI : 10.1097/00001432-200310000-00005

A. Bryceson, Therapy in man The leishmaniases, pp.847-869, 1987.

T. Garnier and S. Croft, Topical treatment for cutaneous leishmaniasis, Curr Opin Investig Drugs, vol.3, pp.538-544, 2002.

A. Asilian, A. Sadeghinia, G. Faghihi, A. Momeni, A. Harandi et al., The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis, Annals of Tropical Medicine & Parasitology, vol.10, issue.5, pp.493-498, 2003.
DOI : 10.1111/j.1365-4362.1996.tb03669.x

P. Guerin, P. Olliaro, S. Sundar, M. Boelaert, and S. Croft, Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda, The Lancet Infectious Diseases, vol.2, issue.8, pp.494-501, 2002.
DOI : 10.1016/S1473-3099(02)00347-X

J. El-on, G. Jacobs, E. Witztum, and C. Greenblatt, Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals., Antimicrobial Agents and Chemotherapy, vol.26, issue.5, pp.745-751, 1984.
DOI : 10.1128/AAC.26.5.745

J. El-on, S. Halevy, M. Grunwald, and L. Weinrauch, Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study, Journal of the American Academy of Dermatology, vol.27, issue.2, pp.227-231, 1992.
DOI : 10.1016/0190-9622(92)70175-F

J. El-on, R. Livshin, Z. Even-paz, D. Hamburger, and L. Weinrauch, Topical Treatment of Cutaneous Leishmaniasis, Journal of Investigative Dermatology, vol.87, issue.2, pp.284-288, 1986.
DOI : 10.1111/1523-1747.ep12696697

B. Arana, C. Mendoza, N. Rizzo, and A. Kroeger, Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala, 2001.

G. Krause and A. Kroeger, Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.1, pp.92-94, 1994.
DOI : 10.1016/0035-9203(94)90517-7

R. Armijos, M. Weigel, M. Calvopina, M. Mancheno, and R. Rodriguez, Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis, Acta Tropica, vol.91, issue.2, pp.153-160, 2004.
DOI : 10.1016/j.actatropica.2004.03.009

A. Asilian, T. Jalayer, J. Whitworth, R. Ghasemi, and M. Nilforooshzadeh, A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran, Am J Trop Med Hyg, vol.53, pp.648-651, 1995.

B. Salah, A. Zakraoui, H. Zaatour, A. Ftaiti, A. Zaafouri et al., A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment, Am J Trop Med Hyg, vol.53, pp.162-166, 1995.

F. Iraji and A. Sadeghinia, Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran, Annals of Tropical Medicine & Parasitology, vol.99, issue.1, pp.3-9, 2005.
DOI : 10.1046/j.1365-4362.1997.00022.x

M. Grogl, B. Schuster, W. Ellis, and J. Berman, Successful Topical Treatment of Murine Cutaneous Leishmaniasis with a Combination of Paromomycin (Aminosidine) and Gentamicin, The Journal of Parasitology, vol.85, issue.2, pp.354-359, 1999.
DOI : 10.2307/3285646

H. Lecoeur, P. Buffet, G. Morizot, S. Goyard, and G. Guigon, Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model, PLoS Neglected Tropical Diseases, vol.68, issue.2, 2007.
DOI : 10.1371/journal.pntd.0000034.g005

URL : https://hal.archives-ouvertes.fr/pasteur-00939156

J. Soto, J. Toledo, P. Gutierrez, M. Arboleda, and R. Nicholls, Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study, Am J Trop Med Hyg, vol.66, pp.147-151, 2002.

G. Lanotte, J. Rioux, J. Lepart, R. Maazoun, and N. Pasteur, Numerical cladistics of the phylogeny of the genus Leishmania Ross, 1903 (Kinetoplastida- Trypanosomatidae) Use of enzyme characteristics, C R Acad Sci III, vol.299, pp.769-772, 1984.

M. Boelaert and J. Dujardin, Diagnostic PCR with Leishmania donovani specificity, Tropical Medicine and International Health, vol.345, issue.11, p.789, 1999.
DOI : 10.1046/j.1365-3156.1999.00416.x

P. Trouiller, P. Olliaro, E. Torreele, J. Orbinski, and R. Laing, Drug development for neglected diseases: a deficient market and a public-health policy failure, The Lancet, vol.359, issue.9324, pp.2188-2194, 2002.
DOI : 10.1016/S0140-6736(02)09096-7

S. Sundar, T. Jha, C. Thakur, P. Sinha, and S. Bhattacharya, Injectable Paromomycin for Visceral Leishmaniasis in India, New England Journal of Medicine, vol.356, issue.25, pp.2571-2581, 2007.
DOI : 10.1056/NEJMoa066536

R. Neal, S. Allen, N. Mccoy, P. Olliaro, and S. Croft, species to aminosidine, Journal of Antimicrobial Chemotherapy, vol.35, issue.5, pp.577-584, 1995.
DOI : 10.1093/jac/35.5.577

O. Ozgoztasi and I. Baydar, A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey, International Journal of Dermatology, vol.36, issue.1, pp.61-63, 1997.
DOI : 10.1046/j.1365-4362.1997.00022.x

I. Sharifi, A. Fekri, M. Aflatonian, A. Nadim, and Y. Nikian, Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, Bull World Health Organ, vol.76, pp.1994-95, 1998.

B. Pecoul, P. Chirac, P. Trouiller, and J. Pinel, Access to Essential Drugs in Poor Countries<SUBTITLE>A Lost Battle?</SUBTITLE>, JAMA, vol.281, issue.4, pp.361-367, 1999.
DOI : 10.1001/jama.281.4.361

A. Magill, Epidemiology of the leishmaniases, Dermatol Clin, vol.13, pp.505-523, 1995.